Actavis expands US product portfolio with new approvals

The company received approval for phendimetrazine tartrate tablets, 35mg the generic equivalent of Bontril tablets by Valeant Pharmaceuticals for the adjunct management of weight loss and buspirone tablets, 30mg, the generic equivalent of Bristol Myers Squibb’s Buspar for anxiety disorders.

And other two products are, baclofen tablets, the generic equivalent of Lioresal tablets by Novartis, will be available in 10mg and 20mg strengths to relax muscles and relieve pain and discomfort associated with certain nerve disorders, and benztropine mesylate tablets, 0.5mg, 1mg, 2mg, the generic equivalent to Cogentin, which reduce the symptoms of Parkinson’s disease by improving muscle control and reducing stiffness.